Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients

University of Lahore278 enrolled

Overview

In current analysis moderate to severely ill Covid-19 infected patients will be nebulized with nitroglycerin, and they will be compared with the standard nebulization

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

278

Conditions

Corona Virus Infection

Interventions

NitroglycerinDRUG

2 mg/ml solution of nitroglycerin used for nebulization four hourly

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: Diagnosed admitted cases of Covid-19 degree of illness should be moderate to severe both male and female every age group Exclusion Criteria: allergic to nitroglycerin sudden drop in blood pressure not given consent

Locations (1)

Bahria Town International Hospital

Lahore, Punjab Province, Pakistan

Outcomes

Primary Outcomes

ratio of partial pressure of oxygen in arterial blood to fraction of inhaled oxygen

Time frame: 5-7 days

Oxygen demand

Time frame: 5-7 days

Secondary Outcomes

Duration of hospital stay

Time frame: 15 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.